Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: A case report
dc.authorid | Erdogan, Esin/0000-0003-0100-652X | |
dc.authorwosid | Erdogan, Esin/AAK-4303-2020 | |
dc.contributor.author | Tuglu, C | |
dc.contributor.author | Erdogan, E | |
dc.contributor.author | Abay, E | |
dc.date.accessioned | 2024-06-12T11:07:44Z | |
dc.date.available | 2024-06-12T11:07:44Z | |
dc.date.issued | 2005 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | We report an elderly patient who developed severe delirium and extrapyramidal signs after initiation of lithium-olanzapine combination. On hospital admission, serum levels of lithium were found to be 3.0 mM/L which were far above toxic level. Immediate discontinuation of both drugs resulted in complete resolution of most of the symptoms except for perioral dyskinesia which persisted for three more months. We critically discussed the differential diagnosis of lithium intoxication and assessed confounding factors which induce delirium and extrapyramidal signs related with combination therapy of lithium and olanzapine. | en_US |
dc.identifier.doi | 10.3346/jkms.2005.20.4.691 | |
dc.identifier.endpage | 694 | en_US |
dc.identifier.issn | 1011-8934 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 16100469 | en_US |
dc.identifier.scopus | 2-s2.0-24644437493 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 691 | en_US |
dc.identifier.uri | https://doi.org/10.3346/jkms.2005.20.4.691 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/22171 | |
dc.identifier.volume | 20 | en_US |
dc.identifier.wos | WOS:000231633500031 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Korean Acad Medical Sciences | en_US |
dc.relation.ispartof | Journal Of Korean Medical Science | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Lithium | en_US |
dc.subject | Drug Toxicity | en_US |
dc.subject | Antipsychotic Agents | en_US |
dc.subject | Olanzapine | en_US |
dc.subject | Delirium | en_US |
dc.subject | Neurologic Manifestations | en_US |
dc.subject | Neuroleptic | en_US |
dc.subject | Neuroleptic Malignant Syndrome | en_US |
dc.subject | Atypical Antipsychotics | en_US |
dc.subject | Neurotoxicity | en_US |
dc.subject | Ketoacidosis | en_US |
dc.subject | Parkinsonism | en_US |
dc.subject | Intoxication | en_US |
dc.subject | Sequelae | en_US |
dc.subject | Patient | en_US |
dc.title | Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: A case report | en_US |
dc.type | Article | en_US |